{"id":649,"date":"2023-10-13T14:46:20","date_gmt":"2023-10-13T14:46:20","guid":{"rendered":"https:\/\/connectwithfund.com\/news\/stock-market-today-live-updates\/"},"modified":"2023-10-13T14:46:21","modified_gmt":"2023-10-13T14:46:21","slug":"stock-market-today-live-updates","status":"publish","type":"post","link":"https:\/\/connectwithfund.com\/?p=649","title":{"rendered":"Stock market today: Live updates"},"content":{"rendered":"<div id=\"107316812-post\">\n<h2 class=\"LiveBlogBody-subtitle\">Novo Nordisk boosts sales and profit forecast on strong Ozempic, Wegovy sales in the U.S. <\/h2>\n<div class=\"group\">\n<p>Danish drugmaker <span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"LiveBlogArticle-QuoteInBody-undefined\">Novo Nordisk<span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"><\/span><\/button><\/span><\/span><\/span> raised its sales and profit forecast for 2023, citing robust sales of its diabetes and weight loss drugs Ozempic and Wegovy in the U.S.<\/p>\n<p>Shares popped as much as 3% in premarket trading after it said 2023 sales growth is anticipated to be in the range of 32% to 38%, up from a prior range of 27% to 33%. Operating profit growth will come in at about 40% to 46%, compared with an earlier estimated increase of 31% to 37%.<\/p>\n<\/div>\n<div>\n<div class=\"Collapsible-proliveCollapsableContainer\" role=\"button\" tabindex=\"0\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"256\" height=\"256\" viewbox=\"0 0 256 256\" aria-labelledby=\"title desc\" role=\"img\" focusable=\"false\" preserveaspectratio=\"xMinYMin\" class=\"Collapsible-stockChartIcon\"><title>Stock Chart Icon<\/title><desc>Stock chart icon<\/desc><g transform=\"translate(1.4065934065934016 1.4065934065934016) scale(2.81 2.81)\"><path d=\"M 87.994 0 H 69.342 c -1.787 0 -2.682 2.16 -1.418 3.424 l 5.795 5.795 l -33.82 33.82 L 28.056 31.196 l -3.174 -3.174 c -1.074 -1.074 -2.815 -1.074 -3.889 0 L 0.805 48.209 c -1.074 1.074 -1.074 2.815 0 3.889 l 3.174 3.174 c 1.074 1.074 2.815 1.074 3.889 0 l 15.069 -15.069 l 14.994 14.994 c 1.074 1.074 2.815 1.074 3.889 0 l 1.614 -1.614 c 0.083 -0.066 0.17 -0.125 0.247 -0.202 l 37.1 -37.1 l 5.795 5.795 C 87.84 23.34 90 22.445 90 20.658 V 2.006 C 90 0.898 89.102 0 87.994 0 z\" transform=\" matrix(1 0 0 1 0 0) \" stroke-linecap=\"round\"><\/path><path d=\"M 65.626 37.8 v 49.45 c 0 1.519 1.231 2.75 2.75 2.75 h 8.782 c 1.519 0 2.75 -1.231 2.75 -2.75 V 23.518 L 65.626 37.8 z\" transform=\" matrix(1 0 0 1 0 0) \" stroke-linecap=\"round\"><\/path><path d=\"M 47.115 56.312 V 87.25 c 0 1.519 1.231 2.75 2.75 2.75 h 8.782 c 1.519 0 2.75 -1.231 2.75 -2.75 V 42.03 L 47.115 56.312 z\" transform=\" matrix(1 0 0 1 0 0) \" stroke-linecap=\"round\"><\/path><path d=\"M 39.876 60.503 c -1.937 0 -3.757 -0.754 -5.127 -2.124 l -6.146 -6.145 V 87.25 c 0 1.519 1.231 2.75 2.75 2.75 h 8.782 c 1.519 0 2.75 -1.231 2.75 -2.75 V 59.844 C 41.952 60.271 40.933 60.503 39.876 60.503 z\" transform=\" matrix(1 0 0 1 0 0) \" stroke-linecap=\"round\"><\/path><path d=\"M 22.937 46.567 L 11.051 58.453 c -0.298 0.298 -0.621 0.562 -0.959 0.8 V 87.25 c 0 1.519 1.231 2.75 2.75 2.75 h 8.782 c 1.519 0 2.75 -1.231 2.75 -2.75 V 48.004 L 22.937 46.567 z\" transform=\" matrix(1 0 0 1 0 0) \" stroke-linecap=\"round\"><\/path><\/g><\/svg><\/p>\n<div class=\"Collapsible-proLivePlayerCloseOrExpand\"><\/div>\n<\/div>\n<p><iframe title=\"Novo Nordisk shares have risen about 4% over the past month.\" src=\"https:\/\/www.cnbc.com\/appchart?symbol=NVO&amp;range=1M&amp;type=mountain&amp;embedded=true&amp;%24DEVICE%24=undefined\" height=\"460\" scrolling=\"no\" style=\"border:0;width:100%\"><\/iframe><\/p>\n<p>Novo Nordisk shares have risen about 4% over the past month.<\/p>\n<\/div>\n<div class=\"group\">\n<p>The company&#8217;s U.S.-traded shares are up more than 48% in the year-to-date period.<\/p>\n<p><em>\u2014Christina Cheddar Berk<\/em><\/p>\n<\/div>\n<\/div>\n<div id=\"107316863-post\">\n<h2 class=\"LiveBlogBody-subtitle\">Consumer sentiment slips, inflation outlook spikes, survey shows<\/h2>\n<div class=\"group\">\n<p>Consumer sentiment slumped in October while inflation expectations spiked, according to the University of Michigan&#8217;s closely watched survey.<\/p>\n<p>The survey posted a headline reading of 63, down from 68.1 in September and below the Dow Jones estimate for 67.4, a preliminary reading released Friday showed. The current conditions index also moved down, to 66.7 from 71.4.<\/p>\n<p>On inflation, the one-year outlook jumped to 3.8%, up from 3.2% and the highest reading since May. On a five-year basis, the outlook moved up to 3% from 2.8%.<\/p>\n<p><em>\u2014Jeff Cox<\/em><\/p>\n<\/div>\n<\/div>\n<div id=\"107316822-post\">\n<h2 class=\"LiveBlogBody-subtitle\">Stocks open higher on Friday<\/h2>\n<div class=\"group\">\n<p>Major stock indexes opened higher on Friday as major banks released earnings.<\/p>\n<p><em>\u2014 Pia Singh<\/em><\/p>\n<\/div>\n<\/div>\n<div id=\"107316817-post\">\n<h2 class=\"LiveBlogBody-subtitle\">Stocks making the biggest moves premarket<\/h2>\n<div class=\"group\">\n<p>Check out the companies making headlines before the bell:<\/p>\n<p>Read the full list here. <\/p>\n<p><em>\u2014 Sarah Min<\/em><\/p>\n<\/div>\n<\/div>\n<div id=\"107316814-post\">\n<h2 class=\"LiveBlogBody-subtitle\">Fed&#8217;s Harker says rates don&#8217;t need to go any higher<\/h2>\n<div class=\"group\">\n<p>In what may be the most explicit endorsement yet of an interest rate freeze, Philadelphia Federal Reserve President Patrick Harker on Friday said the central bank likely has done enough, at least for now.<\/p>\n<p>&#8220;Absent a stark turn in what I see in the data and hear from contacts &#8230; I believe that we are at the point where we can hold rates where they are,&#8221; Harker said in prepared remarks for the Delaware State Chamber of Commerce.<\/p>\n<p>As a voting member this year on the Federal Open Market Committee, Harker&#8217;s words carry extra weight. He added that he won&#8217;t hesitate to vote for higher rates if the inflation data turns, and said he is in the &#8220;higher for longer&#8221; camp on monetary policy.<\/p>\n<p><em>\u2014Jeff Cox<\/em><\/p>\n<\/div>\n<\/div>\n<div id=\"107316773-post\">\n<h2 class=\"LiveBlogBody-subtitle\">Citigroup stocks rises as quarterly revenue tops $20 billion<\/h2>\n<div class=\"group\">\n<p>Shares of Citigroup rose more than 2% in premarket trading after the bank&#8217;s third-quarter report showed stronger-than-expected revenue. <\/p>\n<p>Here is how the bank&#8217;s results compared to estimates from analysts surveyed by LSEG, formally Refinitiv. <\/p>\n<ul>\n<li>Earnings per share: $1.63. Not comparable to the expected $1.21 due to divestitures. Excluding divestitures, earnings per share were $1.52.<\/li>\n<li>Revenue: $20.14 billion, vs. expected $19.31 billion<\/li>\n<\/ul>\n<p>Citigroup saw solid year-over-year growth in both its institutional clients and personal banking and wealth management units. <\/p>\n<p><em>\u2014 Jesse Pound<\/em><\/p>\n<\/div>\n<\/div>\n<div id=\"107316680-post\">\n<h2 class=\"LiveBlogBody-subtitle\">Shares of Dollar General jump on Gordon Haskett upgrade<\/h2>\n<div class=\"group\">\n<p><span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"LiveBlogArticle-QuoteInBody-undefined\">Dollar General<span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"><\/span><\/button><\/span><\/span><\/span>&#8216;s latest leadership change could help re-stabilize the company and put it on track toward growth again, according to research firm Gordon Haskett.\u00a0<\/p>\n<p>Analyst Chuck Grom upgraded shares to buy from hold after the company announced former CEO Todd Vasos\u00a0would be returning and replacing Jeff Owen as chief executive on Thursday. <\/p>\n<p>The stock jumped 7.2% Friday during premarket trading. CNBC Pro subscribers can read more about the upgrade here.<\/p>\n<p><em>\u2014 Hakyung Kim<\/em><\/p>\n<\/div>\n<\/div>\n<div id=\"107316718-post\">\n<h2 class=\"LiveBlogBody-subtitle\">Netflix shares fall 2% Friday premarket<\/h2>\n<div class=\"group\">\n<p><span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"LiveBlogArticle-QuoteInBody-undefined\">Netflix<span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"><\/span><\/button><\/span><\/span><\/span> shed 2% Friday before the bell following a downgrade from Wolfe Research. <\/p>\n<p>Analyst Peter Supino downgraded the streaming service to peer perform from outperform.\u00a0He said the company&#8217;s premium valuation may not be able to hold up against falling growth expectations. <\/p>\n<\/div>\n<div>\n<div class=\"Collapsible-proliveCollapsableContainer\" role=\"button\" tabindex=\"0\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"256\" height=\"256\" viewbox=\"0 0 256 256\" aria-labelledby=\"title desc\" role=\"img\" focusable=\"false\" preserveaspectratio=\"xMinYMin\" class=\"Collapsible-stockChartIcon\"><title>Stock Chart Icon<\/title><desc>Stock chart icon<\/desc><g transform=\"translate(1.4065934065934016 1.4065934065934016) scale(2.81 2.81)\"><path d=\"M 87.994 0 H 69.342 c -1.787 0 -2.682 2.16 -1.418 3.424 l 5.795 5.795 l -33.82 33.82 L 28.056 31.196 l -3.174 -3.174 c -1.074 -1.074 -2.815 -1.074 -3.889 0 L 0.805 48.209 c -1.074 1.074 -1.074 2.815 0 3.889 l 3.174 3.174 c 1.074 1.074 2.815 1.074 3.889 0 l 15.069 -15.069 l 14.994 14.994 c 1.074 1.074 2.815 1.074 3.889 0 l 1.614 -1.614 c 0.083 -0.066 0.17 -0.125 0.247 -0.202 l 37.1 -37.1 l 5.795 5.795 C 87.84 23.34 90 22.445 90 20.658 V 2.006 C 90 0.898 89.102 0 87.994 0 z\" transform=\" matrix(1 0 0 1 0 0) \" stroke-linecap=\"round\"><\/path><path d=\"M 65.626 37.8 v 49.45 c 0 1.519 1.231 2.75 2.75 2.75 h 8.782 c 1.519 0 2.75 -1.231 2.75 -2.75 V 23.518 L 65.626 37.8 z\" transform=\" matrix(1 0 0 1 0 0) \" stroke-linecap=\"round\"><\/path><path d=\"M 47.115 56.312 V 87.25 c 0 1.519 1.231 2.75 2.75 2.75 h 8.782 c 1.519 0 2.75 -1.231 2.75 -2.75 V 42.03 L 47.115 56.312 z\" transform=\" matrix(1 0 0 1 0 0) \" stroke-linecap=\"round\"><\/path><path d=\"M 39.876 60.503 c -1.937 0 -3.757 -0.754 -5.127 -2.124 l -6.146 -6.145 V 87.25 c 0 1.519 1.231 2.75 2.75 2.75 h 8.782 c 1.519 0 2.75 -1.231 2.75 -2.75 V 59.844 C 41.952 60.271 40.933 60.503 39.876 60.503 z\" transform=\" matrix(1 0 0 1 0 0) \" stroke-linecap=\"round\"><\/path><path d=\"M 22.937 46.567 L 11.051 58.453 c -0.298 0.298 -0.621 0.562 -0.959 0.8 V 87.25 c 0 1.519 1.231 2.75 2.75 2.75 h 8.782 c 1.519 0 2.75 -1.231 2.75 -2.75 V 48.004 L 22.937 46.567 z\" transform=\" matrix(1 0 0 1 0 0) \" stroke-linecap=\"round\"><\/path><\/g><\/svg><\/p>\n<div class=\"Collapsible-proLivePlayerCloseOrExpand\"><img decoding=\"async\" src=\"https:\/\/connectwithfund.com\/wp-content\/uploads\/2023\/10\/a54b41835a8b60db28c2.svg.svg+xml\" class=\"Collapsible-dismissButton\" alt=\"hide content\"><\/div>\n<\/div>\n<p><iframe title=\"Netflix shares fall Friday premarket\" src=\"https:\/\/www.cnbc.com\/appchart?symbol=NFLX&amp;range=1D&amp;type=mountain&amp;embedded=true&amp;%24DEVICE%24=undefined\" height=\"460\" scrolling=\"no\" style=\"border:0;width:100%\"><\/iframe><\/p>\n<p>Netflix shares fall Friday premarket<\/p>\n<\/div>\n<div class=\"group\">\n<p>To read more about his downgrade, click here.<\/p>\n<p><em>\u2014 Hakyung Kim<\/em><\/p>\n<\/div>\n<\/div>\n<div id=\"107316693-post\">\n<h2 class=\"LiveBlogBody-subtitle\">UnitedHealth reports better-than-expected earnings, shares jump<\/h2>\n<div class=\"group\">\n<p>UnitedHealth shares were up 1.6% after the health insurance giant posted earnings of $6.56 per share for the third quarter, exceeding an LSEG estimate of $6.32 per share. Revenue of $92.4 billion was also above expectations. <\/p>\n<p>Revenue from premiums and services topped analyst expectations. The company also raised its full-year earnings per share guidance.<\/p>\n<p><em>\u2014 Fred Imbert<\/em><\/p>\n<\/div>\n<\/div>\n<div id=\"107316686-post\">\n<h2 class=\"LiveBlogBody-subtitle\">JPMorgan results top expectations<\/h2>\n<div class=\"group\">\n<p>JPMorgan Chase reported third-quarter revenue of $40.69 billion, more than the LSEG analyst consensus of $39.63 billion. The bank said earnings per share for the period was $4.33, but it was not immediately clear whether that could be compared to the $3.96 consensus estimate from LSEG. It did appear to be a beat, but not clear by how much. Overall, net income was up 24% for the quarter and net revenue was up 15% excluding items related to the First Republic takeover. Higher rates helped the bank more than expected with interest income topping expectations. <\/p>\n<p>There <span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"LiveBlogArticle-QuoteInBody-undefined\">shares<span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"><\/span><\/button><\/span><\/span><\/span> were slightly in the green following the results.<\/p>\n<p>&#8220;Currently, U.S. consumers and businesses generally remain healthy, although, consumers are spending down their excess cash buffers,&#8221; noted CEO Jamie Dimon in the earnings press release.<\/p>\n<p><em>\u2014John Melloy<\/em><\/p>\n<\/div>\n<\/div>\n<div id=\"107316676-post\">\n<h2 class=\"LiveBlogBody-subtitle\">BlackRock reports mixed third-quarter results<\/h2>\n<div class=\"group\">\n<p>Asset management giant <span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"LiveBlogArticle-QuoteInBody-undefined\">BlackRock<span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"><\/span><\/button><\/span><\/span><\/span> reported mixed results for the third quarter, sending the stock slightly lower in the premarket. The company earned $10.91 per share, easily exceeding an LSEG estimate of $8.26 per share. Revenue, however, was in line at $4.52 billion. <\/p>\n<p>&#8220;For the first time in nearly two decades, clients are earning a real return in cash and can wait for more policy and market certainty before re-risking. This dynamic weighed on industry and BlackRock third quarter flows,&#8221; CEO Larry Fink said in a statement.<\/p>\n<p><em>\u2014 Fred Imbert<\/em><\/p>\n<\/div>\n<\/div>\n<div id=\"107316670-post\">\n<h2 class=\"LiveBlogBody-subtitle\">Oil jumps on tighter U.S. sanctions on Russian crude sales<\/h2>\n<\/div>\n<div id=\"107316510-post\">\n<h2 class=\"LiveBlogBody-subtitle\">Watch bank shares ahead of Friday&#8217;s earnings<\/h2>\n<div class=\"group\">\n<p><span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"LiveBlogArticle-QuoteInBody-undefined\">JPMorgan Chase<span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"><\/span><\/button><\/span><\/span><\/span>, <span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"LiveBlogArticle-QuoteInBody-undefined\">Wells Fargo<span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"><\/span><\/button><\/span><\/span><\/span> and <span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"LiveBlogArticle-QuoteInBody-undefined\">Citigroup<span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"><\/span><\/button><\/span><\/span><\/span> are on deck to report their latest quarterly earnings Friday morning.<\/p>\n<p>For 2023, the three stocks are well ahead of the <span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"LiveBlogArticle-QuoteInBody-undefined\">SPDR S&amp;P Bank ETF (KBE)<span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"><\/span><\/button><\/span><\/span><\/span>. JPMorgan is posting an 8.7% gain this year, while Wells Fargo is off nearly 3.8% and Citigroup is down more than 8%. This compares to the nearly 20% loss KBE is facing in a year that has come with higher interest rates and slowing demand for loans.<\/p>\n<\/div>\n<div class=\"group\">\n<p>JPMorgan and Citigroup are close to flat in the past month, but Wells Fargo has lost 6.5% in that period. All three are on pace for modest weekly gains. Friday&#8217;s results could sway the stocks during the session.<\/p>\n<p>Read more about the upcoming bank earnings reports here.<\/p>\n<p>&#8211;<em>Darla Mercado, Ethan Kraft<\/em><\/p>\n<\/div>\n<\/div>\n<div id=\"107316491-post\">\n<h2 class=\"LiveBlogBody-subtitle\">Recovery will be the theme of the third-quarter earnings season, says Ed Yardeni<\/h2>\n<div class=\"group\">\n<p>A strong third-quarter earnings season could set up markets for a year-end rally, according to Ed Yardeni.<\/p>\n<p>The founder of Yardeni Research believes that earnings bottomed out in the second quarter and should be followed be a recovery in the third.<\/p>\n<p>&#8220;What really came down is the profit margin because companies got squeezed but somehow or other, companies are starting to figure out ways to make their profit margin go up. The analysts consensus expectations are showing that,&#8221; he told CNBC&#8217;s &#8220;Closing Bell&#8221; on Thursday.<\/p>\n<p>Against a macroeconomic backdrop of higher rates, Yardeni also believes that mega-cap tech companies could be a good bet, since they don&#8217;t have as much debt and are therefore less exposed to interest rate risks.<\/p>\n<p>&#8220;I think tech could actually turn out to be the safe haven in an environment where interest rates are going to be higher for longer,&#8221; he said.<\/p>\n<p><em>\u2014 Lisa Kailai Han<\/em><\/p>\n<\/div>\n<\/div>\n<div id=\"107316476-post\">\n<h2 class=\"LiveBlogBody-subtitle\">Shares of Dollar General rally nearly 8% in extended trading<\/h2>\n<div class=\"group\">\n<p>Dollar General stock climbed nearly 8% higher in post-market trading hours after the company announced it was reinstating former CEO Todd Vasos.<\/p>\n<\/div>\n<div>\n<div class=\"Collapsible-proliveCollapsableContainer\" role=\"button\" tabindex=\"0\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"256\" height=\"256\" viewbox=\"0 0 256 256\" aria-labelledby=\"title desc\" role=\"img\" focusable=\"false\" preserveaspectratio=\"xMinYMin\" class=\"Collapsible-stockChartIcon\"><title>Stock Chart Icon<\/title><desc>Stock chart icon<\/desc><g transform=\"translate(1.4065934065934016 1.4065934065934016) scale(2.81 2.81)\"><path d=\"M 87.994 0 H 69.342 c -1.787 0 -2.682 2.16 -1.418 3.424 l 5.795 5.795 l -33.82 33.82 L 28.056 31.196 l -3.174 -3.174 c -1.074 -1.074 -2.815 -1.074 -3.889 0 L 0.805 48.209 c -1.074 1.074 -1.074 2.815 0 3.889 l 3.174 3.174 c 1.074 1.074 2.815 1.074 3.889 0 l 15.069 -15.069 l 14.994 14.994 c 1.074 1.074 2.815 1.074 3.889 0 l 1.614 -1.614 c 0.083 -0.066 0.17 -0.125 0.247 -0.202 l 37.1 -37.1 l 5.795 5.795 C 87.84 23.34 90 22.445 90 20.658 V 2.006 C 90 0.898 89.102 0 87.994 0 z\" transform=\" matrix(1 0 0 1 0 0) \" stroke-linecap=\"round\"><\/path><path d=\"M 65.626 37.8 v 49.45 c 0 1.519 1.231 2.75 2.75 2.75 h 8.782 c 1.519 0 2.75 -1.231 2.75 -2.75 V 23.518 L 65.626 37.8 z\" transform=\" matrix(1 0 0 1 0 0) \" stroke-linecap=\"round\"><\/path><path d=\"M 47.115 56.312 V 87.25 c 0 1.519 1.231 2.75 2.75 2.75 h 8.782 c 1.519 0 2.75 -1.231 2.75 -2.75 V 42.03 L 47.115 56.312 z\" transform=\" matrix(1 0 0 1 0 0) \" stroke-linecap=\"round\"><\/path><path d=\"M 39.876 60.503 c -1.937 0 -3.757 -0.754 -5.127 -2.124 l -6.146 -6.145 V 87.25 c 0 1.519 1.231 2.75 2.75 2.75 h 8.782 c 1.519 0 2.75 -1.231 2.75 -2.75 V 59.844 C 41.952 60.271 40.933 60.503 39.876 60.503 z\" transform=\" matrix(1 0 0 1 0 0) \" stroke-linecap=\"round\"><\/path><path d=\"M 22.937 46.567 L 11.051 58.453 c -0.298 0.298 -0.621 0.562 -0.959 0.8 V 87.25 c 0 1.519 1.231 2.75 2.75 2.75 h 8.782 c 1.519 0 2.75 -1.231 2.75 -2.75 V 48.004 L 22.937 46.567 z\" transform=\" matrix(1 0 0 1 0 0) \" stroke-linecap=\"round\"><\/path><\/g><\/svg><\/p>\n<div class=\"Collapsible-proLivePlayerCloseOrExpand\"><img decoding=\"async\" src=\"https:\/\/connectwithfund.com\/wp-content\/uploads\/2023\/10\/a54b41835a8b60db28c2.svg.svg+xml\" class=\"Collapsible-dismissButton\" alt=\"hide content\"><\/div>\n<\/div>\n<p><iframe title=\"DG 1-day chart\" src=\"https:\/\/www.cnbc.com\/appchart?symbol=DG&amp;range=1D&amp;type=mountain&amp;embedded=true&amp;%24DEVICE%24=undefined\" height=\"460\" scrolling=\"no\" style=\"border:0;width:100%\"><\/iframe><\/p>\n<p>DG 1-day chart<\/p>\n<\/div>\n<div class=\"group\">\n<p>Vasos, who held the position from June 2015 to November 2022, will take the reins immediately from successor Jeff Owen. During Owen&#8217;s time in the role, the company faced declining sales growth and mounting criticism for its unsafe working conditions.<\/p>\n<p>On Thursday, Dollar General also lowered its full-year profit guidance. The company now expects earnings of about $7.10 to $7.60 per share, versus prior forecasts of between $7.10 to $8.30 per share.<\/p>\n<p>Read more about Todd Vasos&#8217; return to Dollar General here.<\/p>\n<p><em>\u2014 Lisa Kailai Han, Gabrielle Fonrouge, Jacob Pramuk<\/em><\/p>\n<\/div>\n<\/div>\n<div id=\"107316470-post\">\n<h2 class=\"LiveBlogBody-subtitle\">Stock futures are little changed<\/h2>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/www.cnbc.com\/2023\/10\/12\/stock-market-today-live-updates.html\" target=\"_blank\" rel=\"noopener\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novo Nordisk boosts sales and profit forecast on strong Ozempic, Wegovy sales in the U.S. Danish drugmaker Novo Nordisk raised its sales and profit forecast for 2023, citing robust sales of its diabetes and weight loss drugs Ozempic and Wegovy in the U.S. Shares popped as much as 3% in premarket trading after it said 2023 sales growth is anticipated to be in the range of 32% to 38%, up from a prior range of 27% to 33%. Operating profit growth will come in at about 40% to 46%, compared with an earlier estimated increase of 31% to 37%. Stock<\/p>\n","protected":false},"author":1,"featured_media":650,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42],"tags":[],"class_list":["post-649","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Stock market today: Live updates | ConnectWithFund<\/title>\n<meta name=\"description\" content=\"Novo Nordisk boosts sales and profit forecast on strong Ozempic, Wegovy sales in the U.S. Danish drugmaker Novo Nordisk raised its sales and profit\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/connectwithfund.com\/?p=649\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stock market today: Live updates | ConnectWithFund\" \/>\n<meta property=\"og:description\" content=\"Novo Nordisk boosts sales and profit forecast on strong Ozempic, Wegovy sales in the U.S. Danish drugmaker Novo Nordisk raised its sales and profit\" \/>\n<meta property=\"og:url\" content=\"https:\/\/connectwithfund.com\/?p=649\" \/>\n<meta property=\"og:site_name\" content=\"ConnectWithFund\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-13T14:46:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-13T14:46:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/connectwithfund.com\/wp-content\/uploads\/2023\/10\/107316216-1697128069648-NYSE-Traders-OB-Photo-20231012-CC-Press-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/connectwithfund.com\/?p=649\",\"url\":\"https:\/\/connectwithfund.com\/?p=649\",\"name\":\"Stock market today: Live updates | ConnectWithFund\",\"isPartOf\":{\"@id\":\"https:\/\/connectwithfund.com\/#website\"},\"datePublished\":\"2023-10-13T14:46:20+00:00\",\"dateModified\":\"2023-10-13T14:46:21+00:00\",\"author\":{\"@id\":\"https:\/\/connectwithfund.com\/#\/schema\/person\/9344cb2de07361e178f5c834d2167e52\"},\"description\":\"Novo Nordisk boosts sales and profit forecast on strong Ozempic, Wegovy sales in the U.S. Danish drugmaker Novo Nordisk raised its sales and profit\",\"breadcrumb\":{\"@id\":\"https:\/\/connectwithfund.com\/?p=649#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/connectwithfund.com\/?p=649\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/connectwithfund.com\/?p=649#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/connectwithfund.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stock market today: Live updates\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/connectwithfund.com\/#website\",\"url\":\"https:\/\/connectwithfund.com\/\",\"name\":\"FinMarkPros\",\"description\":\"Latest Finance News and Updates\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/connectwithfund.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/connectwithfund.com\/#\/schema\/person\/9344cb2de07361e178f5c834d2167e52\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/connectwithfund.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3740b286006c76c86a45c4879850da000667bb6f5bbe053edd4a416d2cc4fb80?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3740b286006c76c86a45c4879850da000667bb6f5bbe053edd4a416d2cc4fb80?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/connectwithfund.com\"],\"url\":\"https:\/\/connectwithfund.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stock market today: Live updates | ConnectWithFund","description":"Novo Nordisk boosts sales and profit forecast on strong Ozempic, Wegovy sales in the U.S. Danish drugmaker Novo Nordisk raised its sales and profit","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/connectwithfund.com\/?p=649","og_locale":"en_US","og_type":"article","og_title":"Stock market today: Live updates | ConnectWithFund","og_description":"Novo Nordisk boosts sales and profit forecast on strong Ozempic, Wegovy sales in the U.S. Danish drugmaker Novo Nordisk raised its sales and profit","og_url":"https:\/\/connectwithfund.com\/?p=649","og_site_name":"ConnectWithFund","article_published_time":"2023-10-13T14:46:20+00:00","article_modified_time":"2023-10-13T14:46:21+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/connectwithfund.com\/wp-content\/uploads\/2023\/10\/107316216-1697128069648-NYSE-Traders-OB-Photo-20231012-CC-Press-1.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/connectwithfund.com\/?p=649","url":"https:\/\/connectwithfund.com\/?p=649","name":"Stock market today: Live updates | ConnectWithFund","isPartOf":{"@id":"https:\/\/connectwithfund.com\/#website"},"datePublished":"2023-10-13T14:46:20+00:00","dateModified":"2023-10-13T14:46:21+00:00","author":{"@id":"https:\/\/connectwithfund.com\/#\/schema\/person\/9344cb2de07361e178f5c834d2167e52"},"description":"Novo Nordisk boosts sales and profit forecast on strong Ozempic, Wegovy sales in the U.S. Danish drugmaker Novo Nordisk raised its sales and profit","breadcrumb":{"@id":"https:\/\/connectwithfund.com\/?p=649#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/connectwithfund.com\/?p=649"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/connectwithfund.com\/?p=649#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/connectwithfund.com\/"},{"@type":"ListItem","position":2,"name":"Stock market today: Live updates"}]},{"@type":"WebSite","@id":"https:\/\/connectwithfund.com\/#website","url":"https:\/\/connectwithfund.com\/","name":"FinMarkPros","description":"Latest Finance News and Updates","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/connectwithfund.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/connectwithfund.com\/#\/schema\/person\/9344cb2de07361e178f5c834d2167e52","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/connectwithfund.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3740b286006c76c86a45c4879850da000667bb6f5bbe053edd4a416d2cc4fb80?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3740b286006c76c86a45c4879850da000667bb6f5bbe053edd4a416d2cc4fb80?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/connectwithfund.com"],"url":"https:\/\/connectwithfund.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/connectwithfund.com\/index.php?rest_route=\/wp\/v2\/posts\/649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/connectwithfund.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/connectwithfund.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/connectwithfund.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/connectwithfund.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=649"}],"version-history":[{"count":1,"href":"https:\/\/connectwithfund.com\/index.php?rest_route=\/wp\/v2\/posts\/649\/revisions"}],"predecessor-version":[{"id":651,"href":"https:\/\/connectwithfund.com\/index.php?rest_route=\/wp\/v2\/posts\/649\/revisions\/651"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/connectwithfund.com\/index.php?rest_route=\/wp\/v2\/media\/650"}],"wp:attachment":[{"href":"https:\/\/connectwithfund.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=649"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/connectwithfund.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=649"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/connectwithfund.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}